Article Text

Download PDFPDF
Outcome of trabeculectomy versus Ahmed glaucoma valve implantation in the surgical management of glaucoma in patients with Sturge–Weber syndrome
  1. Bipul Kumer De Sarker1,
  2. Mohammad Ibn Abdul Malek2,
  3. Sheikh M A Mannaf3,
  4. Quazi Sazzad Iftekhar4,
  5. Mallika Mahatma5,
  6. Mridul Kumar Sarkar6,
  7. Mostafizur Rahman2
  1. 1 Ophthalmology–Glaucoma, Ispahani Islamia Eye Institute and Hospital, Dhaka, Bangladesh
  2. 2 Ophthalmology–Retina, Ispahani Islamia Eye Institute and Hospital, Dhaka, Bangladesh
  3. 3 Glaucoma, Ispahani Islamia Eye Institute and Hospital, Dhaka, Bangladesh
  4. 4 Ophthalmology–Paediatric, Paediatric, Ispahani Islamia Eye Institute and Hospital, Dhaka, Bangladesh
  5. 5 Ophthalmology–Pathology, Ispahani Islamia Eye Institute and Hospital, Dhaka, Bangladesh
  6. 6 Ophthalmology–Admin and Quality, Ispahani Islamia Eye Institute and Hospital, Dhaka, Bangladesh
  1. Correspondence to Bipul Kumer De Sarker, Ophthalmology-Glaucoma, Ispahani Islamia Eye Institute and Hospital, Dhaka 1215, Bangladesh; drbipul26{at}gmail.com; bipul.sarker{at}islamia.org.bd

Abstract

Aims To compare the surgical outcomes of trabeculectomy versus Ahmed glaucoma valve (AGV) implantation in the surgical management of glaucoma in patients with Sturge–Weber syndrome (SWS).

Methods A retrospective chart review was performed on 40 eyes of secondary glaucoma in patients with SWS separated into two groups: AGV (N=20) and trabeculectomy with mitomycin C (N=20). Demographic data, intraocular pressure (IOP), visual acuity and the number anti-glaucoma medications (AGM) needed were evaluated prior to and following surgery. Surgical success was defined as an IOP of ≤21 mm Hg, with or without the use of topical AGM. Complete success was achieved when IOP values were obtained without AGM.

Results Mean follow-up duration was 23.15±2.36 months and 22.95±2.87 months in the AGV and trabeculectomy groups, respectively (p=0.811). Both the AGV (34.50±4.65 mm Hg at baseline to 15.20±3.31 mm Hg at last visit) and trabeculectomy (32.10±5.86 mm Hg to 16.10±3.02 mm Hg) groups achieved a statistically significant fall in IOP following surgery (p=0.000). Kaplan–Meier survival of complete success after 24 months was 80% and 70% after AGV implant and trabeculectomy, respectively, but the difference between two groups was not statistically significant (p=0.442).

Conclusions Both AGV implant and trabeculectomy appear to be safe and efficacious in controlling glaucoma secondary to SWS, although the potential for serious complications such as choroidal detachment must be anticipated when planning surgeries in patient with SWS, and the authors recommend the maintenance of a stable IOP during and following the surgery to avoid such complications.

  • Glaucoma
  • Intraocular pressure
  • Treatment Surgery
View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors BKDS and MIAM have equally contributed to the planning of the study, analysis of the data, drafting and revision of the manuscript; SMAM, QSI, MM, MKS and MR: data acquisition, data analysis, review of the paper.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Ethics approval The Institutional Review Board of Ispahani Islamia Eye Institute and Hospital, Dhaka, Bangladesh (number/ID of approval: IIEI&H-ED/2496/2020; 18th review meeting) provided ethical approval for this study.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement Data will available upon reasonable request.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.